CVM.V - CVR Medical Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.34
-0.01 (-2.86%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.35
Open0.35
Bid0.34 x 0
Ask0.35 x 0
Day's Range0.34 - 0.36
52 Week Range0.28 - 0.53
Volume243,740
Avg. Volume137,878
Market Cap23.24M
Beta2.67
PE Ratio (TTM)N/A
EPS (TTM)-0.17
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfilelast month

    CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST (10:00 a.m. PST) is a 7-digit number only. The complete and corrected release follows.Vancouver, British Columbia--(Newsfile Corp. - March ...

  • Newsfilelast month

    CVR Medical Announces Temporary Warrant Exercise Price Amendment

    Company To Host Conference Call Vancouver, British Columbia--(Newsfile Corp. - March 16, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 (the "Amended Exercise Price") for the period commencing on March 16, 2018 and ending ...

  • Newsfile2 months ago

    Second Trial Data Report: Clinical Substantiation for CVR Medical

    Vancouver, British Columbia--(Newsfile Corp. - March 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the prior report, issued in September 2017, which predicted improved accuracy in the ability to identify the narrowing of ...

  • Newsfile2 months ago

    CVR Medical Expands Clinical Footprint

    Vancouver, British Columbia--(Newsfile Corp. - February 27, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director of the Non-Invasive Vascular Laboratory in the Cleveland Clinic Department of Cardiovascular Medicine.Cleveland Clinic was voted the number ...

  • Newsfile2 months ago

    Critical Milestone: CVR Medical to Launch Pivotal Trials

    Vancouver, British Columbia--(Newsfile Corp. - February 20, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone represents the final phase of clinical substantiation which CVR will use to support the upcoming FDA submission. Initially, Thomas Jefferson University Hospital (Philadelphia, PA) and Henry Ford Hospital (Detroit, MI) ...

  • Newsfile2 months ago

    CVR Medical Adds Two Wireless CSS Devices to Methodist Hospital Expanding Clinical Substantiation Data for FDA Submission

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the Thomas Jefferson University Hospital System. This deployment will be combined with the three wireless CSS devices already in use across the Thomas Jefferson University Hospital footprint. This critical milestone will assist ...

  • CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018
    Newsfile2 months ago

    CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018

    Vancouver, British Columbia--(Newsfile Corp. - February 8, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 - 8, 2018), the largest domestic conference and expo for advanced design and manufacturing of plastics technologies. CVI, subsidiary of Canon U.S.A., Inc, is the sole manufacturer of the cart for CVR Medical's "Carotid Stenotic Scan (CSS)" device.CVI is sharing a ...

  • Newsfile2 months ago

    CVR Medical Moving Forward With Touch Panels From Hitachi High Technologies America

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") announces the placement of an initial order of touch panel PC's for its "Carotid Stenotic Scan (CSS)" device. This order represents the preliminary inventory build necessary for an FDA submission and subsequent market launch. Hitachi High Technologies America, Inc. ("HTA") designed the unique core processor for the CSS, which CVR believes ...

  • Newsfile3 months ago

    CVR Medical Entering Into Pre-Pivotal Trial Phase A Step Closer To FDA Clearance

    Vancouver, British Columbia--(Newsfile Corp. - February 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of their Pre-Pivotal Trial clinical substantiation phase for the "Carotid Stenotic Scan (CSS)" device. This critical stage, prior to launch of final phase Pivotal Trials, will be conducted at Thomas Jefferson University Hospital (Philadelphia, PA), Henry Ford Hospital (Detroit, MI), and several other top-tier clinical research institutions within the United States. ...

  • Newsfile3 months ago

    CVR Medical Announces Proposed Financing

    Vancouver, British Columbia--(Newsfile Corp. - January 31, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $2,000,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and one-half of one common share purchase warrant at a price of $0.40 per unit, or such other price per unit determined ...

  • Newsfile3 months ago

    CVR Medical Corp.: Rapid Progress Toward FDA Submission - Clinical Trials Commence At Henry Ford Hospital

    Vancouver, British Columbia--(Newsfile Corp. - January 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the commencement of clinical data acquisition by the Carotid Stenotic Scan (CSS) device at the renowned Henry Ford Hospital. There is currently one wireless CSS device fully deployed within the Henry Ford system, with two additional devices slated for implementation in the subsequent weeks. This clinical trial plays a crucial role in accelerating clinical substantiation for the CSS device and ...

  • CNW Group3 months ago

    IIROC Trading Resumption - CVM

    IIROC Trading Resumption - CVM

  • PR Newswire3 months ago

    IIROC Trading Resumption - CVM

    VANCOUVER , Jan. 18, 2018 /CNW/ - Trading resumes in: Company: CVR Medical Corp. TSX-Venture Symbol: CVM Resumption (ET): 15:00 IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • Newsfile3 months ago

    IIROC Trade Resumption - CVR Medical Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - Trading resumes in: Company: CVR Medical Corp. TSX-V Symbol: CVM ...

  • Newsfile3 months ago

    Clarification of News Release on "CVR Medical Enters China, Executes Preliminary LOI to Launch Its CSS Device in World's Largest Market" Dated January 17, 2018

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - Investment Inventory Regulatory Organization of Canada ("IIROC"), has requested CVR Medical Corp. (TSXV: CVM) ("CVR Medical" or "CVR") to re-state its press release entitled "CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World's Largest Market" dated January 17, 2018, (the "January 17, 2018 Release") with increased specificity with regard to the LOI between CVR Medical and Guangzhou LangRun Equity Investment ...

  • Newsfile3 months ago

    IIROC Trade Halt - CVR Medical Corp.

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - The following issues have been halted by IIROC: Company:  CVR Medical Corp. TSX-V Symbol: CVM ...

  • PR Newswire3 months ago

    IIROC Trading Halt - CVM

    VANCOUVER , Jan. 18, 2018 /CNW/ - The following issues have been halted by IIROC: Company: CVR MEDICAL CORP TSX-Venture Symbol: CVM Reason: Pending Clarification of News Halt Time (ET): 12:11 PM IIROC ...

  • CNW Group3 months ago

    IIROC Trading Halt - CVM

    IIROC Trading Halt - CVM

  • Newsfile3 months ago

    CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World's Largest Market

    Potential To Bring Innovation, Sweeping Change To Healthcare in China Vancouver, British Columbia--(Newsfile Corp. - January 17, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the signing of an official Letter of Intent with Guangzhou LangRun Equity Investment Management Co., Ltd. (GLR), a professional equity investment fund management platform company headquartered in Guangzhou, China. GLR plans to create the "LangRun Asset Fund" focused on ...

  • Newsfile3 months ago

    CVR Medical Eyes Expansion, Global Potential in South Korea

    Vancouver, British Columbia--(Newsfile Corp. - January 11, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the signing of an official Memorandum of Understanding with the Seoul Metropolitan Government (SMG) of the Republic of South Korea. The Understanding states the mutual interest and intended collaboration on new business opportunities as part of CVR's global market expansion and the South Korean government's initiative to revitalize its bio-medical device ...

  • Newsfile3 months ago

    CVR Medical & Henry Ford Hospital - A Giant Leap Forward

    Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce IRB approval of clinical trials for its "Carotid Stenotic Scan (CSS)" device at Michigan's prestigious Henry Ford Hospital. The trials will be overseen by Judith Lin, MD, MBA, RVT, RPVI, Senior Staff Vascular Surgeon and Medical Director of Henry Ford's Clinical Vascular Laboratory.The Henry Ford Health System, founded in ...

  • Newsfile4 months ago

    CVR Medical, Canon Sign Manufacturing Agreement for Breakthrough Device

    Vancouver, British Columbia--(Newsfile Corp. - January 2, 2018) - CVR Medical Corp. (TSX.V: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the signing of a manufacturing agreement with Canon Virginia, Inc., a manufacturing, engineering and technical operation for Canon and a wholly owned subsidiary of Canon U.S.A. The agreement finalizes Canon Virginia's status as primary manufacturer, assembler, and logistical authority for CVR's "Carotid Stenotic Scan (CSS)" device. CVR's novel device, currently undergoing final phase trials ...

  • Newsfile5 months ago

    CVR Medical Meets Critical Milestone! Deploys Wireless System at Thomas Jefferson University

    Vancouver, British Columbia--(Newsfile Corp. - November 21, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the full integration of the "Carotid Stenotic Scan (CSS)" wireless device into its late stage, ongoing clinical trials being conducted at Thomas Jefferson University. The wireless system is the key component of the novel device's efficient and user-friendly design. The wireless Intellectual Property in CVR's portfolio fortifies barrier to entry."We have now ...

  • Newsfile5 months ago

    CVR Medical Teams with Rogan Molding Technologies

    Vancouver, British Columbia--(Newsfile Corp. - November 15, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces partnership with Rogan Molding Technologies. The Northbrook, IL company will be the exclusive manufacturer of the patient-interfacing gel pad for CVR's "Carotid Stenotic Scan (CSS)."Founded in 1934, Rogan Molding Technologies is a staple organization in original equipment manufacturing, and a global leader in the injection molding industry. Being ISO 9001 and 13485 certified, ...

  • Newsfile7 months ago

    CVR Medical Bolsters Finance, Quality Systems with Knisley

    Vancouver, British Columbia--(Newsfile Corp. - September 28, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the addition of Mr. Tim Knisley as Director of Finance and Controlling. Knisley will spearhead the building of CVR's financial systems as they transition from research and development-based to commercial-ready with the launch of the "Carotid Stenotic Scan (CSS)" device.Mr. Tim Knisley has worked in the medical device industry for over twenty ...